title: New-onset diabetes in treated hypertensive patients--is it clinically significant? Roundtable discussion.
authors.forename: Marvin
authors.initials: M
authors.lastname: Moser
authors.forename: James R
authors.initials: JR
authors.lastname: Sowers
authors.forename: Suzanne
authors.initials: S
authors.lastname: Oparil
authors.forename: Henry
authors.initials: H
authors.lastname: Black
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000139:chemically induced / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology*; D012307:Risk Factors; D013997:Time Factors
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors